Nathalie LeVasseur

537 total citations
37 papers, 341 citations indexed

About

Nathalie LeVasseur is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nathalie LeVasseur has authored 37 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 18 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nathalie LeVasseur's work include Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (9 papers) and Cancer survivorship and care (8 papers). Nathalie LeVasseur is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (9 papers) and Cancer survivorship and care (8 papers). Nathalie LeVasseur collaborates with scholars based in Canada, United States and France. Nathalie LeVasseur's co-authors include Stephen Chia, Brian Hutton, Mark Clemons, Risa Shorr, Caroline Lohrisch, Lovedeep Gondara, John Hilton, Caroline Speers, Sasha Mazzarello and Carol Stober and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Nathalie LeVasseur

34 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathalie LeVasseur Canada 11 169 95 92 54 53 37 341
Chunhuan Lao New Zealand 11 188 1.1× 85 0.9× 83 0.9× 11 0.2× 44 0.8× 57 399
Kwonoh Park South Korea 13 112 0.7× 87 0.9× 167 1.8× 40 0.7× 82 1.5× 49 385
Genevieve Lyons United States 11 63 0.4× 119 1.3× 47 0.5× 9 0.2× 118 2.2× 25 408
Mary Nguyen-Nielsen Denmark 10 107 0.6× 70 0.7× 121 1.3× 11 0.2× 32 0.6× 13 389
Livio Blasi Italy 11 189 1.1× 45 0.5× 89 1.0× 7 0.1× 37 0.7× 49 377
Emily N. Kinsey United States 10 82 0.5× 46 0.5× 156 1.7× 23 0.4× 29 0.5× 19 327
Edward Yu Canada 13 143 0.8× 20 0.2× 249 2.7× 13 0.2× 36 0.7× 27 434
Jean-Luc Labourey France 9 131 0.8× 25 0.3× 69 0.8× 45 0.8× 24 0.5× 24 275
Meghan R. Flanagan United States 12 132 0.8× 208 2.2× 43 0.5× 6 0.1× 142 2.7× 33 447
Νικόλαος Παραράς Greece 11 81 0.5× 43 0.5× 66 0.7× 8 0.1× 156 2.9× 37 343

Countries citing papers authored by Nathalie LeVasseur

Since Specialization
Citations

This map shows the geographic impact of Nathalie LeVasseur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathalie LeVasseur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathalie LeVasseur more than expected).

Fields of papers citing papers by Nathalie LeVasseur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathalie LeVasseur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathalie LeVasseur. The network helps show where Nathalie LeVasseur may publish in the future.

Co-authorship network of co-authors of Nathalie LeVasseur

This figure shows the co-authorship network connecting the top 25 collaborators of Nathalie LeVasseur. A scholar is included among the top collaborators of Nathalie LeVasseur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathalie LeVasseur. Nathalie LeVasseur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cescon, David W., Moira Rushton, Nathalie LeVasseur, et al.. (2025). IND.241: A Canadian Cancer Trials Group liquid-biopsy informed platform trial to evaluate treatment in CDK4/6-inhibitor resistant ER+/HER2- metastatic breast.. Journal of Clinical Oncology. 43(16_suppl). 1 indexed citations
2.
Brunet, Jennifer, Monica Taljaard, Nathalie LeVasseur, et al.. (2024). Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE): A randomized controlled trial. Cancer. 131(1). e35540–e35540. 1 indexed citations
3.
4.
Davis, Margot K., Mira Keyes, Nathalie LeVasseur, et al.. (2024). Breast Arterial Calcifications on Mammography: Awareness and Reporting Preferences Amongst Referring Physicians in Canada. Canadian Association of Radiologists Journal. 76(1). 94–104. 2 indexed citations
5.
Bartsch, Rupert, David Cameron, Eva Ciruelos, et al.. (2024). Expert recommendations on treatment sequencing and challenging clinical scenarios in human epidermal growth factor receptor 2-positive (HER2-positive) metastatic breast cancer. Cancer Treatment Reviews. 132. 102853–102853. 3 indexed citations
6.
Wilson, Christine, et al.. (2022). Clinical utility of MRI in the neoadjuvant management of early-stage breast cancer. Breast Cancer Research and Treatment. 194(3). 587–595. 3 indexed citations
7.
LeVasseur, Nathalie, David Fenton, Simon W. Baxter, et al.. (2021). Impact of the 21-Gene Recurrence Score Assay on the Treatment of Estrogen Receptor-Positive, HER2-Negative, Breast Cancer Patients With 1-3 Positive Nodes: A Prospective Clinical Utility Study. Clinical Breast Cancer. 22(1). e74–e79. 9 indexed citations
8.
9.
LeVasseur, Nathalie, Wei Cheng, Sasha Mazzarello, et al.. (2021). Optimising weight-loss interventions in cancer patients—A systematic review and network meta-analysis. PLoS ONE. 16(2). e0245794–e0245794. 17 indexed citations
10.
Chia, Stephen, et al.. (2021). Impact of sequence order of anthracyclines and taxanes in neoadjuvant chemotherapy on pathologic complete response rate in HER2-negative breast cancer patients. Breast Cancer Research and Treatment. 187(1). 167–176. 3 indexed citations
11.
LeVasseur, Nathalie, et al.. (2020). Impact of Recurrence Score on Type and Duration of Chemotherapy in Breast Cancer. Current Oncology. 27(2). 86–92. 1 indexed citations
12.
Fan, Kevin Yijun, Nafisha Lalani, Nathalie LeVasseur, et al.. (2020). Type and timing of systemic therapy use predict overall survival for patients with brain metastases treated with radiation therapy. Journal of Neuro-Oncology. 151(2). 231–240. 5 indexed citations
13.
Lalani, Nafisha, K. David Voduc, Rachel Jimenez, et al.. (2020). Breast Cancer Molecular Subtype as a Predictor of Radiation Therapy Fractionation Sensitivity. International Journal of Radiation Oncology*Biology*Physics. 109(1). 281–287. 12 indexed citations
14.
Brunet, Jennifer, Monica Taljaard, Nathalie LeVasseur, et al.. (2020). Study protocol of the Aerobic exercise and CogniTIVe functioning in women with breAsT cancEr (ACTIVATE) trial: a two-arm, two-centre randomized controlled trial. BMC Cancer. 20(1). 711–711. 4 indexed citations
15.
LeVasseur, Nathalie, et al.. (2019). Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database. Clinical Breast Cancer. 19(6). e683–e689. 12 indexed citations
16.
LeVasseur, Nathalie, Carol Stober, S. Gertler, et al.. (2018). Perceptions of Vascular Access for Intravenous Systemic Therapy and Risk Factors for Lymphedema in Early-Stage Breast Cancer—A Patient Survey. Current Oncology. 25(4). 305–310. 23 indexed citations
17.
LeVasseur, Nathalie, Yaoqing Shen, Eric Y. Stutheit-Zhao, et al.. (2018). Whole genome sequencing in metastatic breast cancer: Lessons learned from the BC Cancer personalized oncogenomics program.. Journal of Clinical Oncology. 36(15_suppl). 12065–12065. 1 indexed citations
18.
LeVasseur, Nathalie, et al.. (2017). Comparing outcomes of neoadjuvant endocrine therapy versus chemotherapy in ER-positive breast cancer: Results from a prospective institutional database.. Journal of Clinical Oncology. 35(15_suppl). 581–581. 2 indexed citations
19.
Dalenc, Florence, Ana B. Rossi, Chantal Bernard-Marty, et al.. (2017). Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study. European Journal of Cancer Care. 27(1). e12735–e12735. 29 indexed citations
20.
LeVasseur, Nathalie, Mark Clemons, Brian Hutton, Risa Shorr, & Carmel Jacobs. (2016). Bone-targeted therapy use in patients with bone metastases from lung cancer: A systematic review of randomized controlled trials. Cancer Treatment Reviews. 50. 183–193. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunhuan Lao Breakdown of academic impact, for papers by Kwonoh Park Breakdown of academic impact, for papers by Genevieve Lyons Breakdown of academic impact, for papers by Mary Nguyen-Nielsen Breakdown of academic impact, for papers by Livio Blasi Breakdown of academic impact, for papers by Emily N. Kinsey Breakdown of academic impact, for papers by Edward Yu Breakdown of academic impact, for papers by Jean-Luc Labourey Breakdown of academic impact, for papers by Meghan R. Flanagan Breakdown of academic impact, for papers by Νικόλαος Παραράς
Rankless by CCL
2026